戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 in for adenylyl cyclase, in complex with the alpha2 adrenergic receptor.
2 h Galphaz coupled strongly to the endogenous alpha2 adrenergic receptor.
3 K1/2 is inhibited by epinephrine through the alpha2-adrenergic receptor.
4 restin is required for ERK activation by the alpha2-adrenergic receptor.
5  inhibition of presynaptic TRPV1 channels by alpha2 adrenergic receptors.
6 y yohimbine, consistent with contribution of alpha2 adrenergic receptors.
7 irming that it was mediated by activation of alpha2 adrenergic receptors.
8 n is specific for post-junctional alpha1- or alpha2-adrenergic receptors.
9 ined whether this was specific to alpha1- or alpha2-adrenergic receptors.
10 ecline (PHFD) requires central activation of alpha2-adrenergic receptors.
11                          GABAB receptors and alpha2-adrenergic receptors (activated by bath applicati
12 te whether transdermal administration of the alpha2 adrenergic-receptor agonist, clonidine, can be us
13                               In humans, the alpha2-adrenergic receptor agonist clonidine increases d
14 ermal administration of the centrally acting alpha2-adrenergic receptor agonist, clonidine), and hypo
15        Significance statement: Clonidine, an alpha2-adrenergic receptor agonist, which decreases the
16 mpatholytic effects we observed suggest that alpha2 adrenergic-receptor agonists may offer a pharmaco
17                                              alpha2-Adrenergic receptor agonists increase in potency
18  syndrome indicates that chronic exposure to alpha2-adrenergic receptor agonists produces strong depe
19 ess in the anti-allodynic effect elicited by alpha2-adrenergic receptor agonists.
20                                          The alpha2 adrenergic receptor (alpha(2)-AR) antagonist yohi
21 ers in cognition and emotion, by alpha1- and alpha2-adrenergic receptors (alpha1-ARs, alpha2-ARs) in
22                                              alpha2 adrenergic receptor (alpha2-AR) agonists have bee
23 ole of arrestins in the trafficking of human alpha2-adrenergic receptors (alpha2-ARs) and the effect
24 the evolutionary precursor to the vertebrate alpha2-adrenergic receptors (alpha2-ARs) based upon sequ
25  the regulation of cell surface transport of alpha2-adrenergic receptors (alpha2-ARs) by GGA3 (Golgi-
26 strates subserving the inhibitory actions of alpha2-adrenergic receptors (alpha2-ARs) in the locus co
27                                              alpha2-Adrenergic receptors (alpha2-ARs) mediate a numbe
28               We report that two subtypes of alpha2-adrenergic receptors (alpha2A/D- and alpha2C-AR)
29 ve, and sympatholytic responses in vivo, and alpha2 adrenergic receptor (alpha2AR) agonists are used
30                                          The alpha2-adrenergic receptor (alpha2AR) subtype alpha2C10
31                                              alpha2-Adrenergic receptors (alpha2ARs) are essential co
32                                          The alpha2-adrenergic receptors (alpha2ARs) are localized to
33                                              alpha2-Adrenergic receptors (alpha2ARs) present in the b
34 ined the selectivity of interactions between alpha2-adrenergic receptors (alpha2R) and various combin
35 ng properties on I1 imidazoline receptors vs alpha2-adrenergic receptors and their blood pressure eff
36 sors are tested for the beta2-, alpha1-, and alpha2- adrenergic receptors, and adenosine type 1 recep
37 rolled by negative feedback from presynaptic alpha2-adrenergic receptors, and the targets of the rele
38 bolished the proepileptogenic actions of the alpha2 adrenergic receptor antagonist idazoxan.
39 factor 1 (CRF1) antagonist (antalarmin), and alpha2-adrenergic receptor antagonist (yohimbine; used a
40 d PLD activity was completely blocked by the alpha2-adrenergic receptor antagonist rauwolscine and by
41 can be reversed by a potent centrally acting alpha2 adrenergic receptor (AR) agonist (dexmedetomidine
42                 Activation of the beta2- and alpha2-adrenergic receptors (AR) involves hydrogen bondi
43                                              alpha2-adrenergic receptors (AR) within the bed nucleus
44 ediated via both post-junctional alpha1- and alpha2-adrenergic receptors are blunted in contracting h
45                                              alpha2-Adrenergic receptors (ARs) play a key role in reg
46 was a result of activation of muscarinic and alpha2-adrenergic receptors because a specific alpha2-ad
47 ms using drug treatments targeting beta- and alpha2-adrenergic receptors, but little is known about t
48 that PHFD does not require the activation of alpha2-adrenergic receptors, but that alpha2-adrenergic
49 ion of alpha2-adrenergic receptors, but that alpha2-adrenergic receptors can modulate resting and pos
50 ctivity, which was increased by 5-HT(1A) and alpha2-adrenergic receptor co-activation in an activator
51 teract with a photoaffinity derivative of an alpha2-adrenergic receptor-derived peptide from the thir
52  voltage-dependent Ca2+ channels mediated by alpha2-adrenergic receptors desensitizes slowly with pro
53 vious studies in several animal species, the alpha2 adrenergic receptors in the human ciliary body, r
54  Stimulated GTPgammaS binding indicated that alpha2-adrenergic receptors in HET hippocampus were more
55 hile rolipram and PDE4D deficiency shortened alpha2 adrenergic receptor-mediated anesthesia, a surrog
56 eleased glutamate in the mNTS and results in alpha2 adrenergic receptor-mediated inhibition of DMV ne
57                We have previously shown that alpha2-adrenergic receptor-mediated coupling to phosphol
58 ctions by approximately 50% and enhanced the alpha2-adrenergic receptor-mediated inhibition of forsko
59 btype influence signaling efficiency for the alpha2-adrenergic receptor-mediated signaling pathway.
60 e from studies in animals demonstrating that alpha2-adrenergic receptor-mediated vasoconstrictor resp
61 he level of arousal by selectively targeting alpha2 adrenergic receptors on LC neurons, resulting in
62 ic actions of norepinephrine are exerted via alpha2 adrenergic receptors residing on targets of norad
63 poptotic effects via activation of beta2 and alpha2 adrenergic receptors, respectively.
64                                Activation of alpha2-adrenergic receptors resulted in a fast, voltage-
65            Here we show that mutation in the alpha2 -adrenergic receptor subtype B (alpha2B -AR) is a
66 cular properties of each Gialpha, Gbeta, and alpha2-adrenergic receptor subtype influence signaling e
67 ecluded understanding the role of individual alpha2 adrenergic receptor subtypes in the antiepileptog
68                       The existence of three alpha2 adrenergic receptor subtypes together with the la
69                                    The three alpha2-adrenergic receptor subtypes (alpha2a, alpha2b, a
70 at low dose SNRIs, by acting on 5-HT(1A) and alpha2-adrenergic receptors, synergistically reduced AMP
71   Here, we show that noradrenaline activates alpha2-adrenergic receptors to control short-term and lo
72 lymorphisms (GPIIb, FcgammaRIIa, P-selectin, alpha2 adrenergic receptor, transforming growth factor [
73 a high binding affinity of M1 muscarinic and alpha2 adrenergic receptors was associated with a greate
74                               The density of alpha2 adrenergic receptors was highest in the iris (440
75                                          The alpha2-adrenergic receptor was found to be markedly more
76 ution and concentration of beta1, beta2, and alpha2 adrenergic receptors were examined in the frontal
77  mice to sedation elicited by stimulation of alpha2 adrenergic receptors, whereas arrestin 3 knockout
78 ne binding sites in plasma membrane and lack alpha2-adrenergic receptors, which recognize many I1-imi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。